Triflusal vs Acetylsalicylic Acid in Secondary Prevention of Cerebral Infarction "TACIP"

Completed

Phase 3 Results

Summary of Purpose

To compare the safety and efficacy of triflusal vs aspirin in secondary stroke prevention.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 May 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • J. Uriach & Cia., Spain and Technifar S.A.

Trial Design

Randomized, double-blind, multicenter parallel trial involving 2113 patients at 43 centers.

Contacts

  • I Paredes and C. Navas. J. Uriach & Cia. Dega Bahi, 59, 08026 Barcelona, Spain.

    rd@uriach.com